These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32627128)

  • 1. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
    Shah AH; Mahavadi A; Di L; Sanjurjo A; Eichberg DG; Borowy V; Figueroa J; Luther E; de la Fuente MI; Semonche A; Ivan ME; Komotar RJ
    J Neurooncol; 2020 Jul; 148(3):501-508. PubMed ID: 32627128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
    J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection.
    Schneider M; Potthoff AL; Keil VC; Güresir Á; Weller J; Borger V; Hamed M; Waha A; Vatter H; Güresir E; Herrlinger U; Schuss P
    J Neurooncol; 2019 Oct; 145(1):143-150. PubMed ID: 31485921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
    Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Jessurun CAC; Versyck G; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Nandoe Tewarie R; Smith TR; Dirven CMF; De Vleeschouwer S; Broekman MLD; Vincent AJPE
    Lancet Oncol; 2022 Jun; 23(6):802-817. PubMed ID: 35569489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?
    Clavreul A; Aubin G; Delion M; Lemée JM; Ter Minassian A; Menei P
    J Neurooncol; 2021 Jan; 151(2):113-121. PubMed ID: 33394262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
    Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
    World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
    Jiang H; Cui Y; Liu X; Ren X; Lin S
    Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobectomy versus gross total resection for glioblastoma multiforme: A systematic review and individual-participant data meta-analysis.
    Zheng Y; Saffari SE; Low DCY; Lin X; Ker JRX; Ang SYL; Ng WH; Wan KR
    J Clin Neurosci; 2023 Sep; 115():60-65. PubMed ID: 37487449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
    Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
    World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.
    Li YC; Chiu HY; Lin YJ; Chen KT; Hsu PW; Huang YC; Chen PY; Wei KC
    Clin Neurol Neurosurg; 2021 Jan; 200():106343. PubMed ID: 33158628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after reoperation for recurrent glioblastoma.
    Woodroffe RW; Zanaty M; Soni N; Mott SL; Helland LC; Pasha A; Maley J; Dhungana N; Jones KA; Monga V; Greenlee JDW
    J Clin Neurosci; 2020 Mar; 73():118-124. PubMed ID: 31987636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates.
    Schneider M; Ilic I; Potthoff AL; Hamed M; Schäfer N; Velten M; Güresir E; Herrlinger U; Borger V; Vatter H; Schuss P
    J Neurooncol; 2020 Sep; 149(3):455-461. PubMed ID: 32990861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive keyhole temporal lobectomy approach for supramaximal glioma resection: A safety and feasibility study.
    Figueroa J; Morell A; Bowory V; Shah AH; Eichberg D; Buttrick SS; Richardson A; Sarkiss C; Ivan ME; Komotar RJ
    J Clin Neurosci; 2020 Feb; 72():57-62. PubMed ID: 31948883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
    Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
    Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma.
    Massaad E; Smith WJ; Bradley J; Esposito E; Gupta M; Burns E; Burns R; Velarde JK; Berglar IK; Gupta R; Martinez-Lage M; Dietrich J; Lennerz JK; Dunn GP; Jones PS; Choi BD; Kim AE; Frosch M; Barker FG; Curry WT; Carter BS; Nahed BV; Cahill DP; Shankar GM
    Neuro Oncol; 2024 Sep; 26(9):1660-1669. PubMed ID: 38581292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
    Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
    J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.